Effective management of infiltrative locally advanced basal cell carcinoma of the tibia with sonidegib

International Journal of DermatologyEarly View Letter to the Editor Effective management of infiltrative locally advanced basal cell carcinoma of the tibia with sonidegib Federico Venturi, Corresponding Author Federico Venturi [email protected] orcid.org/0000-0001-5053-4172 Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy These authors contributed equally to the work.Search for more papers by this authorMartina Lambertini, Martina Lambertini Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy These authors contributed equally to the work.Search for more papers by this authorBarbara Melotti, Barbara Melotti Oncology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalySearch for more papers by this authorMassimiliano De Paolis, Massimiliano De Paolis IRCCS Istituto Ortopedico Rizzoli, Bologna, ItalySearch for more papers by this authorEmi Dika, Emi Dika orcid.org/0000-0003-3186-2861 Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, ItalySearch for more papers by this author Federico Venturi, Corresponding Author Federico Venturi [email protected] orcid.org/0000-0001-5053-4172 Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy These authors contributed equally to the work.Search for more papers by this authorMartina Lambertini, Martina Lambertini Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy These authors contributed equally to the work.Search for more papers by this authorBarbara Melotti, Barbara Melotti Oncology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalySearch for more papers by this authorMassimiliano De Paolis, Massimiliano De Paolis IRCCS Istituto Ortopedico Rizzoli, Bologna, ItalySearch for more papers by this authorEmi Dika, Emi Dika orcid.org/0000-0003-3186-2861 Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, ItalySearch for more papers by this author First published: 13 February 2024 https://doi.org/10.1111/ijd.17083 Conflict of interest: None. Funding source: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012; 366: 2171–2179. https://doi.org/10.1056/NEJMoa1113713 10.1056/NEJMoa1113713 CASPubMedWeb of Science®Google Scholar 2De Giorgi V, Scarfì F, Trane L, Silvestri F, Venturi F, Zuccaro B, et al. Treatment of advanced basal cell carcinoma with hedgehog pathway inhibitors: a multidisciplinary expert meeting. Cancer. 2021; 13:5706. https://doi.org/10.3390/cancers13225706 10.3390/cancers13225706 Google Scholar 3Dika E, Scarfì F, Ferracin M, Broseghini E, Marcelli E, Bortolani B, et al. Basal cell carcinoma: a comprehensive review. Int J Mol Sci. 2020; 21:5572. https://doi.org/10.3390/ijms21155572 10.3390/ijms21155572 CASPubMedWeb of Science®Google Scholar 4Backman E, Oxelblom M, Gillstedt M, Dahlén Gyllencreutz J, Paoli J. Basal cell carcinoma: epidemiological impact of clinical versus histopathological diagnosis. J Eur Acad Dermatol Venereol. 2023; 37: 521–527. https://doi.org/10.1111/jdv.18774 10.1111/jdv.18774 CASPubMedWeb of Science®Google Scholar 5Trane L, Silvestri F, Venturi F, Zuccaro B, Scarfì F, De Giorgi V. The clinical impact of hedgehog pathway inhibitors and statin therapy in the treatment of locally advanced basal cell carcinoma: a case report. Dermatol Ther. 2022; 35:e15191. https://doi.org/10.1111/dth.15191 10.1111/dth.15191 PubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation